Abrahams Neil A, Halverson Amy, Fazio Victor W, Rybicki Lisa A, Goldblum John R
Department of Anatomic Pathology, Cleveland Clinic Foundation, 9500 Euclid Avenue L25, Cleveland, OH 44195, USA.
Dis Colon Rectum. 2002 Nov;45(11):1496-502. doi: 10.1097/01.DCR.0000034134.49346.5E.
Primary small-bowel adenocarcinoma is uncommon. There are few large studies that have evaluated the prognostic impact of clinical and pathologic parameters. The purpose of this study was to perform a comprehensive analysis of the Cleveland Clinic experience with small-bowel adenocarcinoma, with emphasis on histopathologic parameters as prognostic indicators.
Thirty-seven cases of primary small-bowel adenocarcinomas resected at the Cleveland Clinic between 1978 and 1999 were retrospectively studied. Metastatic tumors and those arising from the biliary system were excluded from analysis. Clinical and pathologic data were recorded and their impact on prognosis was evaluated by either Kaplan-Meier or Cox proportional hazards analysis.
The cohort included 25 males, and the age range was 24 to 82 (mean, 56) years. Tumor location was duodenum (18), jejunum (10), ileum (2), and site not specified (7). Patients most frequently presented with abdominal pain (48 percent), anemia (39 percent) and small-bowel obstruction (33 percent). Underlying conditions included Crohn's disease (4) and familial adenomatous polyposis (2). Overall survival was 52 and 47 percent at 5 and 10 years, respectively, with a mean follow-up of 50.5 (range, 0.5-184) months for all patients. Features found to be negative prognostic factors for survival were positive surgical margins (P < 0.001), extramural venous spread (P < 0.001), lymph node metastases (P = 0.038), poor tumor differentiation (P = 0.015), depth of tumor invasion (P = 0.023), and history of Crohn's disease (P < 0.001). Age, gender, tumor size, growth pattern, lymphocytic host response, and adjuvant therapy did not affect survival.
Pathologic features, including positive surgical margins, extramural venous spread, positive lymph nodes, poor tumor differentiation, depth of tumor invasion, and history of Crohn's disease, are of major prognostic significance in small-bowel adenocarcinoma. Although many of these prognostic features are similar to the ones used for colorectal adenocarcinoma, they are easily applicable and reproducible for small-bowel adenocarcinomas. This is important considering the often dismal prognosis of small-bowel adenocarcinoma.
原发性小肠腺癌并不常见。很少有大型研究评估临床和病理参数对预后的影响。本研究的目的是对克利夫兰诊所小肠腺癌的经验进行全面分析,重点是将组织病理学参数作为预后指标。
回顾性研究了1978年至1999年间在克利夫兰诊所切除的37例原发性小肠腺癌病例。分析排除了转移性肿瘤和起源于胆道系统的肿瘤。记录临床和病理数据,并通过Kaplan-Meier或Cox比例风险分析评估它们对预后的影响。
该队列包括25名男性,年龄范围为24至82岁(平均56岁)。肿瘤位置为十二指肠(18例)、空肠(10例)、回肠(2例),未明确部位(7例)。患者最常见的症状为腹痛(48%)、贫血(39%)和小肠梗阻(33%)。基础疾病包括克罗恩病(4例)和家族性腺瘤性息肉病(2例)。所有患者的5年和10年总生存率分别为52%和47%,平均随访时间为50.5个月(范围0.5 - 184个月)。发现对生存有负面预后因素的特征包括手术切缘阳性(P < 0.001)、壁外静脉播散(P < 0.001)、淋巴结转移(P = 0.038)、肿瘤分化差(P = 0.015)、肿瘤浸润深度(P = 0.023)和克罗恩病病史(P < 0.001)。年龄、性别、肿瘤大小、生长模式、淋巴细胞宿主反应和辅助治疗不影响生存。
病理特征,包括手术切缘阳性、壁外静脉播散、淋巴结阳性、肿瘤分化差、肿瘤浸润深度和克罗恩病病史,在小肠腺癌中具有重要的预后意义。虽然这些预后特征中的许多与用于结直肠癌的特征相似,但它们很容易应用于小肠腺癌且具有可重复性。考虑到小肠腺癌通常预后不佳,这一点很重要。